Dermoscribe Seborrheic Dermatitis Cream
Product Images NDC 69683-202

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Dermoscribe Seborrheic Dermatitis (NDC 69683-202). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dermoscribe Pty Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Seb Derm Tube Back View_mar 2025 (Seb Derm Tube Back View Mar 2025)

Drug Facts label on the back of a DERMOSCRIBE SEBORRHEIC DERMATITIS cream tube. Lists active ingredients as Salicylic Acid 3%, Sulfur 3%, and Hydrocortisone 1%. Covers purpose, uses for seborrheic dermatitis symptoms, warnings about external use, eye contact, and medical consultation. Includes directions for application and details inactive ingredients like aloe oil and glycerine.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.